Northwest Biotherapeutics (NWBO) Non-cash Items (2016 - 2026)

Northwest Biotherapeutics' Non-cash Items history runs 11 years deep, the most recent figure standing at -$7.5 million for Q1 2026.

• In Q1 2026, Non-cash Items fell 312.92% year-over-year to -$7.5 million; the TTM figure through Mar 2026 stood at -$8.7 million (down 148.98% YoY), while the FY2025 annual figure was $2.4 million, down 85.46% from the prior year.
• Non-cash Items for Q1 2026 stood at -$7.5 million, up from -$15.2 million in the prior quarter.
• The five-year high for Non-cash Items was $17.0 million in Q3 2022, with the low at -$15.2 million in Q4 2025.
• The 5-year median for Non-cash Items is $3.5 million (2025), against an average of $4.1 million.
• The sharpest annual moves came in 2024 and 2025: Non-cash Items soared 592.87% in 2024, then tumbled 355.56% in 2025.
• Northwest Biotherapeutics' Non-cash Items stood at $16.0 million in 2022, then tumbled by 87.29% to $2.0 million in 2023, then soared by 192.15% to $6.0 million in 2024, then sank by 355.56% to -$15.2 million in 2025, then soared by 50.39% to -$7.5 million in 2026.
• Business Quant data shows NWBO's Non-cash Items at -$7.5 million in Q1 2026, -$15.2 million in Q4 2025, and $10.3 million in Q3 2025.